A spokesman for the Polish government said today that Poland hopes to purchase Johnson & Johnson’s covida-19 vaccine from Denmark, which was previously excluded from the vaccination program due to its possible link with blood clots.
Some Central European countries (such as Poland) want to speed up the vaccination schedule after the vaccine delivery is delayed, so they are less cautious than Denmark. Denmark on Monday became the first country to ban the Johnson & Johnson vaccine.
Last month, Denmark also stopped the vaccination of AstraZenec, which is also due to the rare formation of blood clots after vaccination.
Polish authorities stated that the benefits of vaccination outweigh the possible risks.
Government spokesman Piotr Muller told Reuters by telephone: “Poland has expressed its willingness (to purchase Johnson & Johnson vaccines). The Prime Minister has written to the Danish Prime Minister regarding these vaccines that are allowed to be used in the European market.” news.
Mueller added that Poland is preparing to purchase any vaccines that have been approved by the European Union, including AstraZeneca.
Polsat had previously reported that Polish Prime Minister Mateusz Morawiecki said in a letter to the Danish Prime Minister: “If Denmark decides to sell some of Johnson & Johnson’s stock, Poland is ready to buy it.”
The European Medicines Agency (EMA) announced on April 20 that it has established a possible link between the Johnson & Johnson vaccine and the rare blood clot formation in adults who have received the vaccine in the United States.
However, EMA pointed out that the overall benefits outweigh the risks.
So far, Poland has fully vaccinated 3.1 million of its approximately 38 million inhabitants.